[go: up one dir, main page]

ES2085346T3 - Deteccion de componentes de la membrana basal como diagnostico del cancer y de otras enfermedades. - Google Patents

Deteccion de componentes de la membrana basal como diagnostico del cancer y de otras enfermedades.

Info

Publication number
ES2085346T3
ES2085346T3 ES90901339T ES90901339T ES2085346T3 ES 2085346 T3 ES2085346 T3 ES 2085346T3 ES 90901339 T ES90901339 T ES 90901339T ES 90901339 T ES90901339 T ES 90901339T ES 2085346 T3 ES2085346 T3 ES 2085346T3
Authority
ES
Spain
Prior art keywords
diagnosis
diseases
detection
components
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90901339T
Other languages
English (en)
Inventor
Aken Morgan Van
Stefan L Paskell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Diagnostic Sciences Inc
Original Assignee
Bard Diagnostic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard Diagnostic Sciences Inc filed Critical Bard Diagnostic Sciences Inc
Application granted granted Critical
Publication of ES2085346T3 publication Critical patent/ES2085346T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE EXPONEN LOS METODOS PARA EL DIAGNOSTICO DE ENFERMEDADES QUE DAN COMO RESULTADO LA LIBERACION DE FRAGMENTOS DE UNA MEMBRANA BASE, QUE INCLUYEN LOS FRAGMENTOS, LAS MOLECULAS INTACTAS Y/O LOS COMPLEJOS DE COMPONENTES DE MEMBRANA BASE. LA DETECCION DE LOS FRAGMENTOS DE LA MEMBRANA BASE, DE LAS MOLECULAS INTACTAS Y/O LOS COMPLEJOS EN UN LIQUIDO BIOLOGICO MEDIANTE LOS METODOS INMUNOLOGICOS Y FISICOQUIMICOS DE LA INVENCION ACTUAL PERMITEN EL DIAGNOSTICO DE UNA VARIEDAD DE ENFERMEDADES, INCLUYENDO EL CANCER, LAS ENFERMEDADES DEGENERATIVAS DEL COLAGENO Y LA HEPATITIS. LIQUIDOS BIOLOGICOS IDONEOS QUE INCLUYEN LA ORINA, EL SUERO, EL LIQUIDO SINOVIAL Y EL CEREBROESPINAL.
ES90901339T 1988-12-12 1989-12-11 Deteccion de componentes de la membrana basal como diagnostico del cancer y de otras enfermedades. Expired - Lifetime ES2085346T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28339788A 1988-12-12 1988-12-12

Publications (1)

Publication Number Publication Date
ES2085346T3 true ES2085346T3 (es) 1996-06-01

Family

ID=23085870

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90901339T Expired - Lifetime ES2085346T3 (es) 1988-12-12 1989-12-11 Deteccion de componentes de la membrana basal como diagnostico del cancer y de otras enfermedades.

Country Status (7)

Country Link
EP (2) EP0664453A1 (es)
JP (1) JPH04502363A (es)
AU (1) AU4845390A (es)
CA (1) CA2005190A1 (es)
DE (1) DE68926245T2 (es)
ES (1) ES2085346T3 (es)
WO (1) WO1990007116A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
AU665764B2 (en) * 1991-05-29 1996-01-18 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
AU667500B2 (en) * 1991-12-13 1996-03-28 Bard Diagnostic Sciences, Inc. Agglutination assays and kits employing colloidal dyes
EP0710362B1 (en) * 1993-07-23 1998-11-04 Bard Diagnostic Sciences, Inc. Methods for determining the invasiveness of a bladder tumor
JPH08100000A (ja) * 1994-09-30 1996-04-16 Morinaga & Co Ltd ヒトｉｖ型コラーゲンに対する抗体及びその利用
AU3728595A (en) * 1994-10-18 1996-05-06 Amdl, Inc. Antibodies against an extracellular matrix complex and their use in the detection of cancer
JP5754844B2 (ja) * 2010-03-09 2015-07-29 国立大学法人 東京大学 泌尿器科がんの検査方法及び検査用キット

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923583A1 (de) * 1979-06-11 1980-12-18 Max Planck Gesellschaft Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
JPS59212768A (ja) * 1983-05-18 1984-12-01 Green Cross Corp:The 人胎盤由来基底膜関連蛋白質ｂｍａｐ測定用試薬
DE3410049A1 (de) * 1984-03-19 1985-09-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung der globulaeren domaene von basalmembrankollagen und immunologische bestimmung von basalmembranmaterial und autoantikoerpern
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
FR2606034B1 (fr) * 1986-10-31 1989-06-02 Cird Nouvelle proteine de surface des cellules basales de l'epiderme, anticorps capables de reconnaitre cette proteine, et leur utilisation, et lignees cellulaires hybrides capables de secreter de tels anticorps
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex

Also Published As

Publication number Publication date
DE68926245D1 (de) 1996-05-15
AU4845390A (en) 1990-07-10
WO1990007116A1 (en) 1990-06-28
EP0447490A1 (en) 1991-09-25
EP0664453A1 (en) 1995-07-26
DE68926245T2 (de) 1996-08-22
EP0447490B1 (en) 1996-04-10
JPH04502363A (ja) 1992-04-23
CA2005190A1 (en) 1990-06-12

Similar Documents

Publication Publication Date Title
AR240990A1 (es) Procedimiento para la separacion de moleculas de interes biologico,de una mezcla que las contiene."
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
ES2177964T3 (es) Procedimiento de produccion de celulas t activadas marcadas especificas de tumores y su uso para el tratamiento de tumores.
ES2042058T3 (es) Procedimiento para preparar apoliproteinas a partir de fracciones de plasma sanguineo o suero.
ES2052610T3 (es) Un metodo de determinacion de anfetamina y/o metanfetamina en una muestra de ensayo.
DK0506884T3 (da) Fremgangsmåde til afgivelse af molekyler til eukaryotiske celler
ES2081329T3 (es) Procedimiento para la determinacion de colesterol hdl mediante un diagnostico rapido con etapa de fraccionamiento integrada.
PT97666A (pt) Aparelho para preparar um concentrado de factores de coagulacao a partir de uma amostra de sangue
DE69031804D1 (de) Polymorphie des glykoproteins iiia der menschlichen blutplättchenmembran und diagnostische applikation davon
ATE394474T1 (de) Verfahren zur gewinnung von aktivierten t-zellen und mit antigen inkubierten antigenpräsentierenden zellen
AR026946A1 (es) Osteoprotegerina/receptores de factores de necrosis de tumores
EP0027234A3 (de) Lampenloses Signalelement
MX9207406A (es) Aparato concentrador/extractor que tiene una membrana hidrofobica.
Seegers et al. Heparin and the antithrombic activity of plasma
ES533881A0 (es) Procedimiento para obtener un liquido claro biologico de suero o plasma sanguineo de humano.
ES2085346T3 (es) Deteccion de componentes de la membrana basal como diagnostico del cancer y de otras enfermedades.
ES2040478T3 (es) Aparato y procedimiento de deteccion y de recuento de particulas fluorescentes, soportadas por un soporte solido.
DE3672950D1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ES2118058T3 (es) Factor de crecimiento de las celulas t.
AR022236A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
Sinclair Cysteamine: Differential X-ray protective effect on Chinese hamster cells during the cell cycle
AR022237A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
MX9603619A (es) Microparticulas que contienen gas, medios que contienen el ultimo, su uso en diagnosis ultrasonica, tambien como procesos para la produccion de las particulas y los medios.
ES2054113T3 (es) Sistema de inactivacion viral para bolsas de sangre.
ES2125971T3 (es) Procedimiento para la activacion de factores coagulantes sanguineos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 447490

Country of ref document: ES